A new blood test developed by neuroscientists can reveal whether Alzheimer's is affecting a patient's memory, providing crucial insights for early diagnosis and treatment. This innovation could transform how we understand and address Alzheimer's disease.
A new blood test developed by experts at Washington University and Lund University could change the way Alzheimer’s is diagnosed and treated, identifying disease progression and guiding personalized care.
A groundbreaking blood test developed by researchers may change how Alzheimer's is diagnosed and treated, providing insights into the disease's progression and helping identify suitable medications.
US court upholds convictions of Theranos' founder Elizabeth Holmes and President Ramesh “Sunny” Balwani for defrauding investors in the failed blood testing startup once valued at $9 billion.
